The myth of maximal airway responsiveness in vivo

Research output: Contribution to journalArticle

Abstract

A sine qua non of hyperresponsive airway disease in asthmatic subjects is the lack of a maximal response with increasing doses of aerosol agonist challenge. Normal subjects, however, often appear to exhibit an airway response plateau effect even when challenged with high concentrations of agonist. To investigate this question of maximal narrowing in individual airways in vivo, we used high-resolution computed tomography to visualize canine airways narrowed by two routes of agonist challenge. We compared airway narrowing induced by methacholine (MCh) via the conventional aerosol route to that caused by local atomization of MCh directly to individual airways. Our results showed that, with aerosol challenge, airway responses never reached a truly fiat plateau even at the highest possible nebulizer concentrations. Airway closure was never observed. However, when MCh was delivered directly to the airway luminal surface, airways could be easily narrowed to complete closure at modest (10 mg/ml) agonist concentrations. Thus neither the elastic recoil of the lung nor limitations of smooth muscle shortening can be responsible for the apparent plateauing of dose-response curves. We suggest that the plateau results from limitations associated with the delivery of high concentration of agonists via the aerosol route.

Original languageEnglish (US)
Pages (from-to)2012-2017
Number of pages6
JournalJournal of Applied Physiology
Volume85
Issue number6
StatePublished - Dec 1998

Fingerprint

Aerosols
Methacholine Chloride
Nebulizers and Vaporizers
Smooth Muscle
Canidae
Tomography
Lung

Keywords

  • Airway closure
  • Airways
  • Asthma
  • Dose-response curve
  • High-resolution computed tomography
  • Hyperresponsiveness
  • Methacholine

ASJC Scopus subject areas

  • Physiology
  • Endocrinology
  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

The myth of maximal airway responsiveness in vivo. / Brown, Robert Howard; Mitzner, Wayne A.

In: Journal of Applied Physiology, Vol. 85, No. 6, 12.1998, p. 2012-2017.

Research output: Contribution to journalArticle

@article{80505cc6ff564bab94efc923bd2c3b18,
title = "The myth of maximal airway responsiveness in vivo",
abstract = "A sine qua non of hyperresponsive airway disease in asthmatic subjects is the lack of a maximal response with increasing doses of aerosol agonist challenge. Normal subjects, however, often appear to exhibit an airway response plateau effect even when challenged with high concentrations of agonist. To investigate this question of maximal narrowing in individual airways in vivo, we used high-resolution computed tomography to visualize canine airways narrowed by two routes of agonist challenge. We compared airway narrowing induced by methacholine (MCh) via the conventional aerosol route to that caused by local atomization of MCh directly to individual airways. Our results showed that, with aerosol challenge, airway responses never reached a truly fiat plateau even at the highest possible nebulizer concentrations. Airway closure was never observed. However, when MCh was delivered directly to the airway luminal surface, airways could be easily narrowed to complete closure at modest (10 mg/ml) agonist concentrations. Thus neither the elastic recoil of the lung nor limitations of smooth muscle shortening can be responsible for the apparent plateauing of dose-response curves. We suggest that the plateau results from limitations associated with the delivery of high concentration of agonists via the aerosol route.",
keywords = "Airway closure, Airways, Asthma, Dose-response curve, High-resolution computed tomography, Hyperresponsiveness, Methacholine",
author = "Brown, {Robert Howard} and Mitzner, {Wayne A}",
year = "1998",
month = "12",
language = "English (US)",
volume = "85",
pages = "2012--2017",
journal = "Journal of Applied Physiology",
issn = "0161-7567",
publisher = "American Physiological Society",
number = "6",

}

TY - JOUR

T1 - The myth of maximal airway responsiveness in vivo

AU - Brown, Robert Howard

AU - Mitzner, Wayne A

PY - 1998/12

Y1 - 1998/12

N2 - A sine qua non of hyperresponsive airway disease in asthmatic subjects is the lack of a maximal response with increasing doses of aerosol agonist challenge. Normal subjects, however, often appear to exhibit an airway response plateau effect even when challenged with high concentrations of agonist. To investigate this question of maximal narrowing in individual airways in vivo, we used high-resolution computed tomography to visualize canine airways narrowed by two routes of agonist challenge. We compared airway narrowing induced by methacholine (MCh) via the conventional aerosol route to that caused by local atomization of MCh directly to individual airways. Our results showed that, with aerosol challenge, airway responses never reached a truly fiat plateau even at the highest possible nebulizer concentrations. Airway closure was never observed. However, when MCh was delivered directly to the airway luminal surface, airways could be easily narrowed to complete closure at modest (10 mg/ml) agonist concentrations. Thus neither the elastic recoil of the lung nor limitations of smooth muscle shortening can be responsible for the apparent plateauing of dose-response curves. We suggest that the plateau results from limitations associated with the delivery of high concentration of agonists via the aerosol route.

AB - A sine qua non of hyperresponsive airway disease in asthmatic subjects is the lack of a maximal response with increasing doses of aerosol agonist challenge. Normal subjects, however, often appear to exhibit an airway response plateau effect even when challenged with high concentrations of agonist. To investigate this question of maximal narrowing in individual airways in vivo, we used high-resolution computed tomography to visualize canine airways narrowed by two routes of agonist challenge. We compared airway narrowing induced by methacholine (MCh) via the conventional aerosol route to that caused by local atomization of MCh directly to individual airways. Our results showed that, with aerosol challenge, airway responses never reached a truly fiat plateau even at the highest possible nebulizer concentrations. Airway closure was never observed. However, when MCh was delivered directly to the airway luminal surface, airways could be easily narrowed to complete closure at modest (10 mg/ml) agonist concentrations. Thus neither the elastic recoil of the lung nor limitations of smooth muscle shortening can be responsible for the apparent plateauing of dose-response curves. We suggest that the plateau results from limitations associated with the delivery of high concentration of agonists via the aerosol route.

KW - Airway closure

KW - Airways

KW - Asthma

KW - Dose-response curve

KW - High-resolution computed tomography

KW - Hyperresponsiveness

KW - Methacholine

UR - http://www.scopus.com/inward/record.url?scp=0031792957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031792957&partnerID=8YFLogxK

M3 - Article

C2 - 9843520

AN - SCOPUS:0031792957

VL - 85

SP - 2012

EP - 2017

JO - Journal of Applied Physiology

JF - Journal of Applied Physiology

SN - 0161-7567

IS - 6

ER -